INS and metabolic syndrome: Of these three most-detected phthalate metabolites in our study, MiBP showed a significant positive correlation with key indicators of obesity and metabolic syndrome, including fat mass (p = 0.012), fasting insulin (p = 0.002), and insulin resistance (HOMA-IR; p = 0.0004).